Clinical Trial Update: INNO-206 in Patients With Small Cell Lung Cancer (SCLC) [Phase 2]

View source ↗

Summary

CytRx has withdrawn its Phase 2 clinical trial of INNO-206 for small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• INNO-206

Snippet

Sponsor: CytRx | Conditions: Small Cell Lung Cancer | Phase 2 | Status: WITHDRAWN